
OPAL Clinical Trial
21 posts

OPAL Clinical Trial
@OPALstudy
OPAL is a world first placebo-controlled trial of opioid analgesia for acute spinal pain.





Another congratulations to Professor Andrew McLachlan, Head of School and Dean of Pharmacy who became a Member of the Order of Australia, announced in the 2018 Queen's Birthday Honours. Andrew received this award for significant service to #pharmacy: bit.ly/2JzlzTN







Congratulations to our first Finalist in the 2018 ACTA Trial of the Year Award and an honourable mention for the Excellence in Trial Statistics Award, the PRECISE Trial! The award was accepted by @DrChristineLin and Prof Jane Latimer.

We worked with people to capture their stories about person-centred musculoskeletal pain care:see stories and pain management videos painhealth.csse.uwa.edu.au twitter.com/anyadei/status…












